Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cream combo tested for scalp bumps in men of african descent

NCT ID NCT05608499

First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 40 times

Summary

This study tested Duobrii, a prescription cream that combines a strong steroid with a retinoid, for treating early-mild acne keloidalis nuchae (AKN) — a chronic scalp condition causing bumps and scarring, mainly in men of African descent. The trial planned to enroll 15 adults with mild AKN and track changes in lesion counts over 12 weeks. However, the study was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE KELOIDALIS NUCHAE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029, United States

Conditions

The condition(s) this trial relates to.

acne keloid acrokeratosis verruciformis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.